{"id":"NCT01901185","sponsor":"Amgen","briefTitle":"Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept","officialTitle":"A Single-arm, Multicenter Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Electromechanical Autoinjector to Self-inject Etanercept","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06-11","primaryCompletion":"2013-12-18","completion":"2013-12-30","firstPosted":"2013-07-17","resultsPosted":"2014-11-21","lastUpdate":"2018-09-04"},"enrollment":77,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis","Psoriatic Arthritis"],"interventions":[{"type":"DRUG","name":"Etanercept / Autoinjector A","otherNames":["Enbrel®"]}],"arms":[{"label":"Etanercept / Autoinjector A","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the ability of people with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) to use an experimental autoinjector to self inject etanercept (Enbrel®).","primaryOutcome":{"measure":"Percentage of Successful Self-injections to Total Non-missed Injections","timeFrame":"Week 1, Week 2, Week 3, Week 4 and Week 5","effectByArm":[{"arm":"Etanercept / Autoinjector A","deltaMin":97.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":13,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":75},"commonTop":["Injection site pain","Injection site reaction"]}}